Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on April 23, 2018. The filing reports on the Company's results of operations for the quarter ended March 31, 2018, and details events occurring at the Annual Meeting of Shareholders held on the same date. The Company is incorporated in Delaware and operates in the industrial manufacturing sector.
Key Financial Metrics and Asbestos Liability
While specific revenue, profit, and cash flow figures for the quarter are referenced in an attached press release (Exhibit 99.1) and not detailed in the text of this filing, the document provides extensive data regarding asbestos-related liabilities and costs:
- Asbestos Liability: The total estimated asbestos liability was $596 million as of March 31, 2018, down from $696 million as of December 31, 2016. The current portion of this liability is $85 million.
- Insurance Recoveries: An asset of $108 million was recorded as of March 31, 2018, representing probable insurance reimbursements.
- Costs Incurred (Q1 2018): Total settlement and defense costs incurred were $14.8 million ($8.3 million for settlements/indemnity and $6.5 million for defense).
- Cash Payments (Q1 2018): Pre-tax cash payments for settlements and defense, net of insurance receipts, totaled $2.9 million.
- Pending Claims: There were 30,990 pending asbestos claims as of March 31, 2018.
Material Changes and Corporate Governance
The filing highlights several material changes and governance events:
- Board Resignation: Peter Scannell resigned from the Board of Directors effective April 23, 2018.
- Director Elections: Seven directors were elected to serve until the 2019 Annual Meeting. All nominees received a majority of votes cast in favor.
- Shareholder Approvals: Stockholders approved the selection of Deloitte & Touche LLP as independent auditors, the advisory compensation of named executive officers, and the 2018 Stock Incentive Plan.
- Asbestos Activity: New claims filed in Q1 2018 were 608, compared to 818 in Q4 2017. Settlements and dismissals reduced the total pending claims count.
Outlook, Risks, and Contingencies
Management provided significant commentary on the uncertainties surrounding asbestos litigation:
- Liability Estimate Stability: Management determined that no change to the asbestos liability estimate was warranted for the period ended March 31, 2018, as actual experience approximated assumptions.
- Forecast Period: The liability estimate covers claims projected through 2059. Cash payments are expected to continue for years beyond this date due to the lag between filing and resolution.
- Key Risks: The ultimate exposure is subject to significant uncertainties, including the number of new mesothelioma claims, average settlement costs, dismissal rates, and defense costs. Legislative changes or adverse verdicts could materially alter the liability estimate.
- Insurance Coverage: The Company has "coverage-in-place" agreements with eleven excess insurer groups and has settled obligations with ten others. Approximately 21% of the liability is expected to be reimbursed by insurers.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q1 2018 revenue, net income, and cash flow figures not included in this text.
- Verify the status of the $596 million asbestos liability and the $108 million insurance receivable in the most recent 10-Q or 10-K filings.
- Monitor the outcome of the Richard DeLisle claim appeal, which was argued before the Florida Supreme Court in March 2018.
- Assess the impact of the 2018 Stock Incentive Plan approval on future equity dilution.
- Track the number of new mesothelioma claims filed, as this is a primary driver of the liability estimate.